Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WelChol + Zetia in Primary Hypercholesterolemia
NCT00185107Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2005
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypercholesterolemia comparing WelChol + Zetia + Simvastatin with Placebo + Zetia + Simvastatin (2 arms). Primary endpoint: Percent Change in Low-Density Lipoprotein Cholesterol at 10 weeks. Started Mar 2005; status: completed.
02
Drugs
colesevelam
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00185107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185107.